HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a renal transplant recipient.

Abstract
In patients who have not undergone transplantation, Guillain-Barré syndrome (GBS) is typically preceded by an acute infection often sustained by Campylobacter jejuni. Thus far, in renal transplant recipients, only eight cases of GBS have been reported. In seven patients GBS was attributed to cytomegalovirus infection and in the eighth patient to cyclosporin A neurotoxicity. We report here the case of a GBS in a renal transplant recipient following C. jejuni bacteremia. The infection quickly disappeared after erythromycin and methronidazole therapy. GBS progressively evolved into a paraparesis within 1 week. After reaching a plateau phase, the clinical status improved and the patient was able to walk unassisted after 3 weeks. At this last check-up, 54 months later, the patient was doing well with a functioning graft and only minimal weakness of the lower limbs.
AuthorsM Maccario, A Tarantino, E Nobile-Orazio, C Ponticelli
JournalTransplant international : official journal of the European Society for Organ Transplantation (Transpl Int) Vol. 11 Issue 6 Pg. 439-42 ( 1998) ISSN: 0934-0874 [Print] Switzerland
PMID9870273 (Publication Type: Case Reports, Journal Article)
Topics
  • Bacteremia (complications, etiology)
  • Campylobacter Infections (complications, etiology)
  • Campylobacter jejuni
  • Humans
  • Kidney Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Polyradiculoneuropathy (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: